Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial (Q34327991)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

0 references

circulatory system

1 reference

based on heuristic

inferred from title

Alberto Zanchetti

object named as

Alberto Zanchetti

14

0 references

Sverre E. Kjeldsen

2

object named as

Sverre E Kjeldsen

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

author name string

Stevo Julius

1

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Michael Weber

3

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Hans R Brunner

4

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Steffan Ekman

5

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Lennart Hansson

6

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Tsushung Hua

7

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

John Laragh

8

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Gordon T McInnes

9

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Lada Mitchell

10

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Francis Plat

11

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Anthony Schork

12

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Beverly Smith

13

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

VALUE trial group

15

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

language of work or name

0 references

publication date

1 June 2004

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

363

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

9426

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

2022-2031

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Shanghai trial of nifedipine in the elderly (STONE)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916451-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916451-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension. Systolic Hypertension in China (Syst-China) Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916451-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916451-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916451-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916451-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916451-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916451-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916451-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Principal Results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916451-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Calcium antagonist lacidipine slows down progression of asymptomatic carotid atherosclerosis: principal results of the European Lacidipine Study on Atherosclerosis (ELSA), a randomized, double-blind, long-term trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916451-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916451-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Cardiovascular prevention and blood pressure reduction: a quantitative overview updated until 1 March 2003.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916451-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916451-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916451-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of outcomes with angiotensin-converting--enzyme inhibitors and diuretics for hypertension in the elderly.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916451-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial of cardiovascular events in hypertension. Rationale and design

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916451-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Characteristics of 15,314 hypertensive patients at high coronary risk. The VALUE trial. The Valsartan Antihypertensive Long-term Use Evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916451-9

7 January 2021

based on heuristic

inferred from DOI database lookup

VALUE trial: Long-term blood pressure trends in 13,449 patients with hypertension and high cardiovascular risk

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916451-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Experimental and clinical evidence that angiotensin II is an independent risk factor for cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916451-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Blood pressure, stroke, and coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916451-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Electrocardiographic identification of increased left ventricular mass by simple voltage-duration products

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916451-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Electrocardiographic identification of left ventricular hypertrophy: test performance in relation to definition of hypertrophy and presence of obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916451-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916451-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916451-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916451-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose-response efficacy of valsartan, a new angiotensin II receptor blocker

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916451-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916451-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916451-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of isolated systolic hypertension: the SHELL study results

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916451-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduction of sympathetic hyperactivity by enalapril in patients with chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916451-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Are β-Blockers Efficacious as First-line Therapy for Hypertension in the Elderly?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916451-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916451-9

7 January 2021

based on heuristic

inferred from DOI database lookup

2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916451-9

7 January 2021

based on heuristic

inferred from DOI database lookup

2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916451-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(04)16451-9

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34327991&oldid=1547260563"